Irvin R, Ward K, Agee T, Nelson NP, Vellozzi C, Thomas DL, Millman AJ. Comparison of hepatitis C virus testing recommendations in high-income countries. World J Hepatol 2018; 10(10): 743-751 [PMID: 30386467 DOI: 10.4254/wjh.v10.i10.743]
Corresponding Author of This Article
Risha Irvin, MD, Assistant Professor, Division of Infectious Diseases, Johns Hopkins University School of Medicine, 725 N Wolfe Street, Room 218A,Baltimore, MD 21205, United States. rirvin1@jhmi.edu
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Evidence-Based Medicine
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Irvin R, Ward K, Agee T, Nelson NP, Vellozzi C, Thomas DL, Millman AJ. Comparison of hepatitis C virus testing recommendations in high-income countries. World J Hepatol 2018; 10(10): 743-751 [PMID: 30386467 DOI: 10.4254/wjh.v10.i10.743]
World J Hepatol. Oct 27, 2018; 10(10): 743-751 Published online Oct 27, 2018. doi: 10.4254/wjh.v10.i10.743
Comparison of hepatitis C virus testing recommendations in high-income countries
Risha Irvin, Kathleen Ward, Tracy Agee, Noele P Nelson, Claudia Vellozzi, David L Thomas, Alexander J Millman
Risha Irvin, Kathleen Ward, Tracy Agee, David L Thomas, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States
Noele P Nelson, Claudia Vellozzi, Alexander J Millman, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30329, United States
Author contributions: Irvin R, Nelson NP, Vellozzi C, Thomas DL and Millman AJ developed the concept and search strategy for the manuscript; Irvin R, Ward K and Agee T performed all relevant data searches; Irvin R, Ward K, Agee T, Nelson NP, Vellozzi C, Thomas DL and Millman AJ reviewed all data obtained from searches and participated in manuscript preparation.
Supported byCenters for Disease Control and Prevention, contract No. 200-2013-M-57552; additional support was provided to the primary author by the Johns Hopkins University Center for AIDS Research, No. 1P30AI094189 and NIDA, No. R37DA013806 (to Thomas DL).
Conflict-of-interest statement: Dr. Irvin has nothing to disclose. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Correspondence to: Risha Irvin, MD, Assistant Professor, Division of Infectious Diseases, Johns Hopkins University School of Medicine, 725 N Wolfe Street, Room 218A,Baltimore, MD 21205, United States. rirvin1@jhmi.edu
Telephone: +1-443-2874843
Received: May 5, 2018 Peer-review started: May 5, 2018 First decision: June 5, 2018 Revised: June 27, 2018 Accepted: July 9, 2018 Article in press: July 10, 2018 Published online: October 27, 2018 Processing time: 175 Days and 13.8 Hours
Core Tip
Core tip: This report investigates hepatitis C virus (HCV) testing recommendations from the United States and other high-income countries to assess any risk-based or universal screening categories that should be considered for updates to HCV testing guidance from the HCV Guidance Panel (United States). This review affirmed the similarities of the HCV Panel guidance with those of very high-income countries. No significant gaps in the guidance were identified. HCV testing recommendations from very high-income countries will be continually reviewed and as new risk categories or universal screening recommendations are identified, they will be considered for incorporation into the HCV Panel guidance when peer-reviewed evidence is available to support the incorporation of the HCV testing practices in the United States.
